title: Treatment motivation in drug users: a theory-based analysis.
abstract: Motivation for drug use treatment is widely regarded as crucial to a client's engagement in treatment and success in quitting drug use. Motivation is typically measured with items reflecting high treatment readiness (e.g., perceived need for treatment and commitment to participate) and low treatment resistance (e.g., skepticism regarding benefits of treatment). Building upon reactance theory and the psychotherapeutic construct of resistance, we conceptualized these two aspects of treatment motivation - readiness and resistance - as distinct constructs and examined their predictive power in a sample of 1295 drug-using offenders referred to treatment while on probation. The sample was 60.7% African Americans, 33.5% non-Hispanic Whites, and 21.2% women; their ages ranged from 16 to 63 years old. Interviews occurred at treatment entry and 6 months later. Readiness (but not resistance) predicted treatment retention during the 6-month period. Resistance (but not readiness) predicted drug use, especially among offenders for whom the treatment referral was coercive. These findings suggest that readiness and resistance should both be assessed among clients entering treatment, especially when the referral is coercive. Intake and counseling protocols should address readiness and resistance separately.
authors.affiliation: Integrated Substance Abuse Programs, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA 90025, USA. dlongsho@ucla.edu
authors.forename: Douglas
authors.initials: D
authors.lastname: Longshore
authors.forename: Cheryl
authors.initials: C
authors.lastname: Teruya
mesh_terms: D000328:Adult; D000367:Age Factors; D003068:Coercion; D005260:Female; D006801:Humans; D008297:Male; D009042:Motivation; D010342:Patient Acceptance of Health Care; D011329:Prisoners; D011582:Psychological Theory; D044469:Racial Groups; D012737:Sex Factors; D016320:Substance Abuse Treatment Centers; D019966:Substance-Related Disorders / Q000628:therapy*